Overall rates of low-value diagnostic cardiovascular testing—including imaging—have dropped over the past 10 years, while rates of high-value, guideline-recommended testing rose slightly.

The use of AI continues to rise throughout the United States, according to a new industry report published by RELX. The report included feedback from more than 1,000 senior-level executives representing seven industries: healthcare, science/medical, government, insurance, legal, banking and agriculture.

“The impact of this groundbreaking solution for patients and healthcare providers is substantial," said President Brian Fleming. 

The global market for implantable pacemakers is projected to see moderate, steady growth through 2023, resulting in a sum of more than $5.32 billion, according to a recent report.

MaxQ AI has announced that its AI-based intracranial hemorrhage (ICH) and stroke software will soon be integrated into Philips CT scanners.

A drop in income over six years was linked to a higher likelihood of CVD in a recent analysis of the ARIC study, suggesting financial stress might be a predictor of worse heart health in the U.S.

VIDA Diagnostics, a Coralville, Iowa-based medical imaging company, has announced a new distribution deal with TeraRecon.

Radiology is evolving, consolidating and all the while innovating in this time of transition from volume to value across U.S. healthcare. A compressed field reflects the shape of the changed—and still changing—marketplace.